Global Alzheimer’s Platform Foundation (GAP) has partnered with Eli Lilly and Company (NYSE: LLY) for a study comparing blood tests that could help predict and…
Posts published in “Eli Lilly”
Brain diagnostics company Amprion recently closed $6 million from a $15 million total Series B financing round to expand the company’s commercial reach and enhance…
Swiss-based biotech company Asceneuron has successfully raised an additional $100 million for the development of drug therapies that target proteins linked to Alzheimer’s disease and…
Doctors have a new drug to prescribe to treat Alzheimer’s disease. Earlier this month, the U.S. Food and Drug Administration (FDA) approved the use of…
An experimental Alzheimer’s drug has received unanimous approval from a Food and Drug Administration advisory panel. The drug, called donanemab, is made by Eli Lilly…
A new blood test that could help identify Alzheimer’s earlier from healthcare company Roche has received a Breakthrough Device Designation from the U.S. Food and…
Pharmaceutical giant Eli Lilly (NYSE: LLY) on Monday launched a late-stage clinical trial in long-term care facilities for its Covid-19 antibody treatment. The Phase 3…